Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis.
Syed Shahzad HasanToby CapstickRaees AhmedChia Siang KowFaizan MazharHamid A MerchantSyed Tabish Razi ZaidiPublished in: Expert review of respiratory medicine (2020)
The high mortality in COVID-19 associated ARDS necessitates a prompt and aggressive treatment strategy which includes corticosteroids. Most of the studies included no information on the dosing regimen of corticosteroid therapy, however, low-dose corticosteroid therapy or pulse corticosteroid therapy appears to have a beneficial role in the management of severely ill COVID-19 patients.
Keyphrases
- acute respiratory distress syndrome
- sars cov
- low dose
- extracorporeal membrane oxygenation
- mechanical ventilation
- coronavirus disease
- cardiovascular events
- type diabetes
- stem cells
- blood pressure
- high dose
- coronary artery disease
- mesenchymal stem cells
- health information
- respiratory syndrome coronavirus
- case control